Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial

BACKGROUND: When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in patients with metastatic breast cancer. The SUCCESS-A trial...

Descripción completa

Detalles Bibliográficos
Autores principales: de Gregorio, Amelie, Häberle, Lothar, Fasching, Peter A., Müller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Friedl, Thomas W. P., Bauer, Emanuel, de Gregorio, Nikolaus, Deniz, Miriam, Fink, Visnja, Bekes, Inga, Andergassen, Ulrich, Schneeweiss, Andreas, Tesch, Hans, Mahner, Sven, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Lato, Krisztian, Beckmann, Matthias W., Rack, Brigitte, Janni, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583247/
https://www.ncbi.nlm.nih.gov/pubmed/33097092
http://dx.doi.org/10.1186/s13058-020-01348-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583247/
https://www.ncbi.nlm.nih.gov/pubmed/33097092
http://dx.doi.org/10.1186/s13058-020-01348-w

Ejemplares similares